Haemodynamic profile of captopril treatment in various forms of hypertension

[1]  J. Morton,et al.  Evidence that the acute hypotensive effect of captopril in dogs is not wholly explained by a reduction of plasma angiotensin II and its direct vasoconstrictor effect. , 1980, Clinical science.

[2]  J. Brown,et al.  Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition. , 1980, British heart journal.

[3]  W. Kirkendall,et al.  The captopril-induced eruption. A possible mechanism: cutaneous kinin potentiation. , 1980, Archives of dermatology.

[4]  J. Brown,et al.  COMBINED TREATMENT OF SEVERE INTRACTABLE HYPERTENSION WITH CAPTOPRIL AND DIURETIC , 1980, The Lancet.

[5]  B. Rajagopalan,et al.  CAPTOPRIL AND FRUSEMIDE IN SEVERE DRUG-RESISTANT HYPERTENSION , 1980, The Lancet.

[6]  N. Hollenberg,et al.  Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man. , 1980, The Journal of clinical investigation.

[7]  J. Laragh,et al.  Endocrine and cardiovascular influences of converting enzyme inhibition with SQ 14225 in hypertensive patients in the supine position and during head-up tilt before and after sodium depletion. , 1980, The Journal of clinical endocrinology and metabolism.

[8]  H. Gavras,et al.  Discrepancy Between Antihypertensive Effect and Angiotensin Converting Enzyme Inhibition by Captopril , 1980, Hypertension.

[9]  A. J. Man in 't Veld,et al.  Effects of an angiotensin-converting enzyme inhibitor (captopril) on blood pressure in anephric subjects. , 1980, British medical journal.

[10]  F. Gross,et al.  Pharmacology and clinical use of angiotensin I converting enzyme inhibitors : first International Symposium on Captopril, Munich, May 4th, 1979 , 1980 .

[11]  N. Markandu,et al.  Essential hypertension: effect of an oral inhibitor of angiotensin-converting enzyme. , 1979, British medical journal.

[12]  J. Robertson,et al.  CAPTOPRIL IN THE TREATMENT OF CLINICAL HYPERTENSION AND CARDIAC FAILURE , 1979, The Lancet.

[13]  J. Conway,et al.  The effect of angiotensin converting enzyme inhibitor on baroreceptor reflexes in conscious dogs during sodium depletion [proceedings]. , 1979, The Journal of physiology.

[14]  M. Schalekamp,et al.  Activation of inactive plasma renin by plasma and tissue kallikreins. , 1979, Clinical science.

[15]  C. Johnston,et al.  LONG-TERM EFFECTS OF CAPTOPRIL (SQ14 225) ON BLOOD-PRESSURE AND HORMONE LEVELS IN ESSENTIAL HYPERTENSION , 1979, The Lancet.

[16]  N. Hollenberg,et al.  Converting Enzyme Inhibition in Essential Hypertension: The Hypotensive Response Does Not Reflect Only Reduced Angiotensin II Formation , 1979, Hypertension.

[17]  R. Tarazi,et al.  Converting Enzyme Inhibition with an Orally Active Compound in Hypertensive Man , 1979, Hypertension.

[18]  H. Gavras,et al.  Oral angiotensin-converting enzyme inhibitor in long-term treatment of hypertensive patients. , 1979, Annals of internal medicine.

[19]  J. Laragh,et al.  Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients. , 1978, Progress in cardiovascular diseases.

[20]  H. Gavras,et al.  Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in man. , 1978, The New England journal of medicine.

[21]  H. Ibsen,et al.  Renin--angiotensin system in mild essential hypertension. The functional significance of angiotensin II in untreated and thiazide-treated hypertensive patients. , 1978, Clinical science and molecular medicine. Supplement.

[22]  A. Zanchetti,et al.  Relationship between the hypotensive and renin-stimulating actions of diuretic therapy in hypertensive patients. , 1978, Clinical science and molecular medicine. Supplement.

[23]  A. J. Man in 't Veld,et al.  Quantitative radiocardiography by single-probe counting using 99mtechnetium albumin: clinical application in follow-up studies. , 1978, The Netherlands journal of medicine.

[24]  H. Yager,et al.  Drugs in the management of hypertension. Part I. , 1976, American heart journal.

[25]  N. Kaplan,et al.  Propranolol in the treatment of hypertension. , 1976, The New England journal of medicine.

[26]  R. Elliott.  WRINKLING OF SKIN IN CYSTIC FIBROSIS , 1974 .

[27]  W. Birkenhäger,et al.  Studies on the mechanism of hypernatriuresis in essential hypertension in relation to measurements of plasma renin concentration, body fluid compartments and renal function. , 1971, Clinical science.

[28]  P. Gillam,et al.  Treatment of Hypertension with Propranolol , 1969, British medical journal.

[29]  G. A. Rose,et al.  A SPHYGMOMANOMETER FOR EPIDEMIOLOGISTS. , 1964, Lancet.

[30]  E. Brandstrup,et al.  Foetal and neonatal mortality. , 1947, Lancet.

[31]  A. Sheild.  Death from Anæsthetics , 1881, The Dental register.